Metabolic dysfunction–associated fatty liver disease and the risk of 24 specific cancers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic dysfunction–associated fatty liver disease and the risk of 24 specific cancers
Authors
Keywords
MAFLD, Cancer, Obesity, Metabolic dysfunction, Smoking, Alcohol intake
Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 127, Issue -, Pages 154955
Publisher
Elsevier BV
Online
2021-12-14
DOI
10.1016/j.metabol.2021.154955
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study
- (2021) Solange Parra-Soto et al. BMC Medicine
- On the proposed definition of metabolic associated fatty liver disease
- (2021) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- The sub-Saharan Africa position statement on the redefinition of fatty liver disease: from NAFLD to MAFLD
- (2021) C.Wendy Spearman et al. JOURNAL OF HEPATOLOGY
- From the origin of NASH to the future of metabolic fatty liver disease
- (2021) Andreas Geier et al. GUT
- Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists
- (2021) Yasser Fouad et al. JOURNAL OF HEPATOLOGY
- Cancer Risk in Patients With Biopsy‐Confirmed Nonalcoholic Fatty Liver Disease: A Population‐Based Cohort Study
- (2021) Tracey G. Simon et al. HEPATOLOGY
- Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes
- (2021) Mian Li et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease
- (2020) Jung Il Lee et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- rs641738C>T near MBOAT7 is associated with liver fat, ALT, and fibrosis in NAFLD: a meta-analysis
- (2020) Kevin Teo et al. JOURNAL OF HEPATOLOGY
- Redefining fatty liver disease: an international patient perspective
- (2020) Gamal Shiha et al. Lancet Gastroenterology & Hepatology
- The health impact of MAFLD, a novel disease cluster of NAFLD, is amplified by the integrated effect of fatty liver disease related genetic variants
- (2020) Zhenqiu Liu et al. Clinical Gastroenterology and Hepatology
- “Dual aetiology fatty liver disease”: A recently proposed term associated with potential pitfalls
- (2020) Christophe Moreno et al. JOURNAL OF HEPATOLOGY
- MAFLD and risk of CKD
- (2020) Dan-Qin Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
- (2020) Cristiana Bianco et al. JOURNAL OF HEPATOLOGY
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease
- (2019) Fredrik Åberg et al. Clinical Gastroenterology and Hepatology
- The Risk of Incident Extrahepatic Cancers is higher in Nonalcoholic Fatty Liver Disease than Obesity - a Longitudinal Cohort Study
- (2019) Alina M. Allen et al. JOURNAL OF HEPATOLOGY
- Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis
- (2018) Felix Stickel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer incidence among Finnish people with type 2 diabetes during 1989–2014
- (2018) Katri Saarela et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK
- (2018) Krishnan Bhaskaran et al. Lancet Diabetes & Endocrinology
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis
- (2016) Edmondo Falleti et al. DIGESTIVE AND LIVER DISEASE
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
- (2016) Jakub Dobruch et al. EUROPEAN UROLOGY
- Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
- (2016) Zobair Younossi et al. GASTROENTEROLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
- (2015) Cathie Sudlow et al. PLOS MEDICINE
- The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
- (2014) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults
- (2014) Krishnan Bhaskaran et al. LANCET
- Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO)
- (2013) A C Pesatori et al. BRITISH JOURNAL OF CANCER
- Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene
- (2013) Hwa-Li Tan et al. JOURNAL OF GASTROENTEROLOGY
- The biliary tree—a reservoir of multipotent stem cells
- (2012) Vincenzo Cardinale et al. Nature Reviews Gastroenterology & Hepatology
- Diverse Roles for Sex Hormone-Binding Globulin in Reproduction
- (2011) G. L. Hammond BIOLOGY OF REPRODUCTION
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
- (2011) Silvia Sookoian et al. HEPATOLOGY
- Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
- (2010) Luca Valenti et al. HEPATOLOGY
- A feed-forward loop amplifies nutritional regulation of PNPLA3
- (2010) Yongcheng Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now